Eyegenex Inc.
PrivateLast Round
Pre Seed
Sep 6, 2023
Total Funding Raised
$745,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Eyegenex Inc. is a biotechnology company that develops gene and peptide therapies for the treatment of glaucoma and diabetic retinopathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eyegenex Inc. Comparables
Compare Eyegenex Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allgenesis Biotherapeutics Inc. | 78% | |
| Diorasis Therapeutics | 78% | |
| Life Biosciences | 77% |
Eyegenex Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Sep 6, 2023 |
Key People
Founding team and executive leadership
Eyegenex Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newsight Tech Angels | Pre Seed |
| NuFund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 39% MoM.
- Nov 26, 2024
Grew from 3 to 7 employees this quarter.
Eyegenex Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eyegenex Inc.'s valuation, stock price, and market status.
Is Eyegenex Inc. a public or private company?
Eyegenex Inc. is a private company.
What is the current stock price of Eyegenex Inc.?
Eyegenex Inc. is a private company, so its shares have no public market price. Caplight tracks Eyegenex Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eyegenex Inc. worth (valuation)?
Valuation information for Eyegenex Inc. is not publicly available.
Can I buy Eyegenex Inc. stock?
Eyegenex Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eyegenex Inc.'s last funding round?
Eyegenex Inc.'s most recent funding round was Pre Seed on September 6, 2023.
Who are the main investors in Eyegenex Inc.?
Key investors in Eyegenex Inc. include Newsight Tech Angels, NuFund.
Will Eyegenex Inc. IPO soon?
No public IPO plans have been announced for Eyegenex Inc..
How can I track Eyegenex Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Eyegenex Inc.'s shares on secondary markets.